Skip to content

Clinical trials

Phase 2/3 trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Greece Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20054
20061
20071
20084
20093
20107
20114
20126
20134
20141
20162
20175
20186
201912
20206
20219
20229
20233
20245
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting24
Terminated15
Active, not recruiting11
Unknown status9
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Patras9
Bristol-Myers Squibb7
Genesis Athens Clinic5
Merck Sharp & Dohme LLC5
National and Kapodistrian University of Athens5
Janssen Research & Development, LLC4
Pfizer4
Sanofi4
Boehringer Ingelheim3
Celgene3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-195
Carcinoma, Non-Small-Cell Lung4
Colitis, Ulcerative4
Infertility4
Infertility, Female4
Breast Neoplasms3
Crohn Disease3
Head and Neck Neoplasms3
Inflammatory Bowel Diseases3
Lung Neoplasms3

Trials

Showing 51 to 75 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.